Trientine Hydrochloride
6 NDCs across 6 manufacturers|6 Generic,0 Brand
Trientine Hydrochloride is used to treat nervous system heavy metal poisoning and hepatolenticular degeneration, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 8, 1985, and the first generic was approved Feb 7, 2018. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient.
Trientine Hydrochloride is available as 6 NDCs from 6 manufacturers (6 generic, 0 brand), with NADAC prices from $2.30 to $2.84 per EA — a 23% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
6G / 0B
Manufacturers
6
competing in market
Price Spread
$2.30 – $2.84
per EA
7d Activity
avg +0.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Actavis Pharma, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing TRIENTINE HYDROCHLORIDE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRIENTINE HCL 250 MG CAPSULE | $2.8388 per EA | — |
TRIENTINE HCL 250 MG CAPSULE | $2.3025 per EA | — |
TRIENTINE HCL 250 MG CAPSULE | $2.3025 per EA | — |
TRIENTINE HCL 250 MG CAPSULE | $2.3025 per EA | — |
TRIENTINE HCL 250 MG CAPSULE | $2.3025 per EA | — |
TRIENTINE HCL 250 MG CAPSULE | $2.3025 per EA | — |
Frequently Asked Questions
What is Trientine Hydrochloride used to treat?
Trientine Hydrochloride is used to treat nervous system heavy metal poisoning and hepatolenticular degeneration, per the National Library of Medicine's MED-RT classification.
When did Trientine Hydrochloride become available as a generic?
FDA approved the first generic Trientine Hydrochloride (ANDA) on Feb 7, 2018. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Trientine Hydrochloride products are on the market?
The Trientine Hydrochloride drug market contains 6 NDCs from 6 manufacturers — 6 generic and 0 brand products.
What is the price range for Trientine Hydrochloride?
NADAC reference prices for Trientine Hydrochloride range from $2.3025 to $2.8388 per EA — a 23% difference between cheapest and most expensive.
Which manufacturers make Trientine Hydrochloride?
6 manufacturers list Trientine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Actavis Pharma, Inc. (1), Endo USA Inc. (1), Novadoz Pharmaceuticals LLC (1), Camber Pharmaceuticals Inc. (1), Rising Pharma Holdings Inc. (1).